Not applicableStudy completedNCT02360267What this trial is testingPediatric Bipolar RegistryWho this might be right forBipolar DisorderDepressionMania+1 more The University of Texas Health Science Center, Houston 334
Large-scale testing (Phase 3)Study completedNCT00723450What this trial is testingLamictal as Add-on Treatment for Bipolar I Disorder in Pediatric PatientsWho this might be right forBipolar Disorder GlaxoSmithKline 301
Large-scale testing (Phase 3)Study completedNCT02046369What this trial is testingLurasidone Pediatric Bipolar StudyWho this might be right forBipolar I Depression Sumitomo Pharma America, Inc. 350
Early research (Phase 1)Study completedNCT01620060What this trial is testingLurasidone Pediatric Pharmacokinetics StudyWho this might be right forSchizophreniaAutism Sumitomo Pharma America, Inc. 105
Not applicableStudy completedNCT01804582What this trial is testingThe Family VOICE StudyWho this might be right forAutismAggressionBipolar Disorder+1 more University of Maryland, Baltimore 350
Large-scale testing (Phase 3)Ended earlyNCT01504659What this trial is testingIntranasal Ketamine In the Treatment of Pediatric Bipolar DisorderWho this might be right forBipolar Disorder Juvenile Bipolar Research Foundation 5
Post-approval studies (Phase 4)Study completedNCT01050582What this trial is testingEvaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in ChildrenWho this might be right forSchizophreniaBipolar DisorderAutistic Disorder+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244
Early research (Phase 1)Study completedNCT04987658What this trial is testingPhase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I DisorderWho this might be right forBipolar I Disorder Alkermes, Inc. 7
Large-scale testing (Phase 3)Enrolling By InvitationNCT04987229What this trial is testingLong-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsWho this might be right forBipolar I DisorderSchizophrenia Alkermes, Inc. 236
Large-scale testing (Phase 3)Looking for participantsNCT04777357What this trial is testingAssess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Who this might be right forDepressionBipolar I Disorder AbbVie 380
Large-scale testing (Phase 3)Study completedNCT01914393What this trial is testingPediatric Open-Label Extension StudyWho this might be right forSchizophreniaAutismBipolar Depression Sumitomo Pharma America, Inc. 702